Assembly Biosciences, Inc. (ASMB) vs Kamada Ltd. (KMDA)
A side-by-side comparison of Assembly Biosciences, Inc. and Kamada Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$22.07HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
KMDA
Kamada Ltd.
$8.17HealthcareDelayed quote: Oct 6, 2026, 2:34 PM EDT
Total return — ASMB vs KMDA
growth of $100 · dividends reinvested · last 10yASMB -76.4% (-13.4%/yr)KMDA +65.0% (+5.1%/yr)KMDA compounded faster over this window
Log scale — wide-divergence pair
ASMB KMDA
ASMB vs KMDA: by the numbers
- •KMDA is the larger company ($471M vs $437M market cap).
- •KMDA trades at the lower trailing earnings multiple (21.56 vs 40.13 P/E), one valuation lens rather than an overall verdict.
- •KMDA is profitable (11.60% net margin) while ASMB runs a net loss (-0.06%).
- •KMDA grew revenue faster over the past five years (10.59% vs -1.78% CAGR).
- •KMDA pays a dividend (5.25% yield), while ASMB has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ASMB | KMDA |
|---|---|---|
| P/E ratio | 40.13 | 21.56 |
| Forward P/E | N/A | 17.11 |
| P/S ratio | 5.84 | 2.46 |
| P/B ratio | 1.43 | 1.75 |
| EV / EBITDA | N/A | 10.52 |
| FCF yield | N/A | 5.62% |
Profitability
| Metric | ASMB | KMDA |
|---|---|---|
| Gross margin | 99.82% | 40.82% |
| Operating margin | -11.75% | 14.51% |
| Net margin | -0.06% | 11.60% |
| ROE | -0.01% | 8.25% |
| ROIC | -2.86% | 6.95% |
Dividends
| Metric | ASMB | KMDA |
|---|---|---|
| Dividend yield | N/A | 5.25% |
| Payout ratio | N/A | 110.82% |
Growth (annualized)
| Metric | ASMB | KMDA |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | 10.59% |
| EPS CAGR (5Y) | N/A | -1.98% |
| FCF CAGR (5Y) | N/A | 40.37% |
| Total return CAGR (5Y) | -10.66% | 10.36% |
Frequently asked
- Which has the lower trailing P/E, ASMB or KMDA?
- KMDA has the lower trailing P/E: ASMB trades at 40.13 and KMDA at 21.56. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ASMB or KMDA?
- Over the past five years, KMDA grew revenue faster — ASMB at a -1.78% CAGR versus KMDA at 10.59%.
- Does ASMB or KMDA pay a bigger dividend?
- KMDA pays a dividend (5.25% yield), while ASMB has no payments in the available dividend history.
- Is ASMB or KMDA more profitable?
- KMDA runs the higher net margin — ASMB at -0.06% versus KMDA at 11.60%.
- How have ASMB and KMDA total returns compared?
- Over the past 10 years, ASMB delivered -13.41% and KMDA delivered 5.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Assembly Biosciences P/E ratioKamada P/E ratioKamada dividend yieldAssembly Biosciences ROEKamada ROEAssembly Biosciences operating marginKamada operating marginAssembly Biosciences revenue growthKamada revenue growthAssembly Biosciences free cash flowKamada free cash flow
Assembly Biosciences & Kamada appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.